The Substrate Domain of BCAR1 Is Essential for Anti-Estrogen-Resistant Proliferation of Human Breast Cancer Cells

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-009-0403-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Β-Catenin Deacetylation Is Essential for WNT-induced Proliferation of Breast Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

GPER‐induced Signaling Is Essential for the Survival of Breast Cancer Stem Cells

International Journal of Cancer
Cancer ResearchOncology
2019English

SALL4 Is Essential for Cancer Cell Proliferation and Is Overexpressed at Early Clinical Stages in Breast Cancer

International Journal of Oncology
Cancer ResearchOncology
2011English

Evaluation of Synthetic Isoflavones on Cell Proliferation, Estrogen Receptor Binding Affinity, and Apoptosis in Human Breast Cancer Cells

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2008English

Expression of the Aryl Hydrocarbon Receptor Is Not Required for the Proliferation, Migration, Invasion, or Estrogen-Dependent Tumorigenesis of McF-7 Breast Cancer Cells

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2012English

Local Estrogen Axis in the Human Bone Microenvironment Regulates Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2017English

The Death Domain of FADD Is Essential for Embryogenesis, Lymphocyte Development, and Proliferation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy